GenMont Biotech Inc Cash Flow Reinvestment Rate
GenMont Biotech Inc cash flow reinvestment rate. GenMont Biotech Inc (3164) has a Cash Flow Reinvestment Rate of 0.01x as of March 2026, reinvesting NT$230.00K (capex NT$230.00K ) from operating cash flow of NT$15.46 Million. Explore GenMont Biotech Inc (3164) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of GenMont Biotech Inc (2005–2025)
Cash flow reinvestment rate of GenMont Biotech Inc from 2005 to 2025. Historical reinvestment intensity for GenMont Biotech Inc across 18 annual periods. Explore GenMont Biotech Inc (3164) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
GenMont Biotech Inc Cash Flow Reinvestment Rate by Year (2005–2025)
GenMont Biotech Inc cash flow reinvestment rate by year from 2005 to 2025. Year-by-year capital reinvestment analysis for GenMont Biotech Inc. For the full cash flow conversion analysis, see GenMont Biotech Inc (3164) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$13.54 Million | NT$73.60 Million | NT$3.65 Million | ▼ -72.9% |
| 2024 | 0.68x | NT$84.03 Million | NT$123.95 Million | NT$44.27 Million | ▼ -78.9% |
| 2023 | 3.21x | NT$110.91 Million | NT$34.60 Million | NT$35.54 Million | ▲ +423.0% |
| 2022 | 0.61x | NT$84.55 Million | NT$137.95 Million | NT$70.93 Million | ▼ -60.9% |
| 2021 | 1.57x | NT$175.07 Million | NT$111.66 Million | NT$117.12 Million | ▼ -34.6% |
| 2020 | 2.40x | NT$283.51 Million | NT$118.27 Million | NT$138.99 Million | ▼ -76.5% |
| 2019 | 10.21x | NT$760.52 Million | NT$74.52 Million | NT$393.72 Million | ▼ -26.9% |
| 2018 | 13.95x | NT$781.83 Million | NT$56.03 Million | NT$275.30 Million | ▲ +943.6% |
| 2017 | 1.34x | NT$103.70 Million | NT$77.56 Million | NT$28.25 Million | ▼ -12.1% |
| 2016 | 1.52x | NT$68.99 Million | NT$45.34 Million | NT$32.57 Million | ▲ +63.9% |
| 2013 | 0.93x | NT$93.18 Million | NT$100.37 Million | NT$10.54 Million | ▲ +422.4% |
| 2011 | 0.18x | NT$7.10 Million | NT$39.94 Million | NT$7.10 Million | ▲ +94.1% |
| 2010 | 0.09x | NT$18.32 Million | NT$200.03 Million | NT$18.32 Million | ▼ -53.8% |
| 2009 | 0.20x | NT$21.52 Million | NT$108.53 Million | NT$21.52 Million | ▼ -50.5% |
| 2008 | 0.40x | NT$40.30 Million | NT$100.62 Million | NT$40.30 Million | ▼ -73.0% |
| 2007 | 1.48x | NT$64.37 Million | NT$43.36 Million | NT$64.37 Million | ▲ +1203.2% |
| 2006 | 0.11x | NT$3.37 Million | NT$29.56 Million | NT$3.37 Million | ▼ -82.6% |
| 2005 | 0.65x | NT$6.24 Million | NT$9.53 Million | NT$6.24 Million | — |